SODIUM BICARBONATE CLAIMS FOR OVERINDULGENCE WILL BE DISALLOWED BY FDA
This article was originally published in The Tan Sheet
Executive Summary
SODIUM BICARBONATE CLAIMS FOR OVERINDULGENCE WILL BE DISALLOWED BY FDA in response to reports of rare, but potentially fatal, gastric ruptures. Under separate proposed amendments to the antacid final monograph and the internal analgesic tentative final monograph published in the Feb. 2 Federal Register, companies selling OTC products containing sodium bicarbonate or the combination of an analgesic and sodium bicarbonate would no longer be allowed to use the claims: "for the relief of over indulgence in food and drink" and "for relief of hangover."